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ABSTRACT 
 
Ryan J. Viverette: Influence of Castration and and a High Protein Diet on Load-Mediated 
Hypertrophy and Skeletal Muscle Force Production in Rats Following Immobilization 
(Under the direction of Erik Hanson) 
 
The purpose of the present study to was to to examine the effects of low testosterone on 
muscle mass and function in rats following 10 days of hindlimb immobilization and determine if 
a high protein diet enhances load-mediated hypertrophy. Average SOL CSA was significantly 
lower for immobilized vs. control legs at 0 (30.3%, p < 0.001) and 14 days of reloading (15.9%, p 
= 0.006). Significant differences in average soleus mass were present at all days of reloading (all 
p < 0.001). Immobilized SOL Po followed a similar pattern (all p < 0.001), and castrated animals 
showed lower Po at 14 days (p < 0.050). At present, functional overload in a testosterone-deprived 
state appears to reduce the regrowth of skeletal muscle size, suggesting that testosterone may play 
a role in load-mediated hypertrophy following immobilization. As well, a high protein diet did not 
result in enhanced load-mediated hypertrophy in castrated rats.  
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CHAPTER I 
INTRODUCTION 
 
Basis for Study: 
The loss of endogenous testosterone, as a result of normal aging or pharmacological 
intervention for prostate cancer therapy, has adverse effects on skeletal muscle mass, strength, 
function, and physical activity levels (Basaria et al., 2008). It is estimated that hypogonadism 
affects between 2.1 - 12.8% of adult males in the general population (Zarotsky et al., 2014). 
Primary hypogonadism is a result of a defect within the Leydig cells of the testes in males, while 
secondary hypogonadism occurs elsewhere, often within the hypothalamic-pituitary gonadal 
(HPG) axis. Androgen deprivation therapy (ADT) is a form of  prostate cancer treatment that 
suppresses male sex hormone production to help slow the progression of prostate cancer by 
preventing the pituitary from releasing lutenizing hormone (LH) or through the use of 
antiandrogens antagonists (Sharifi et al., 2010). Regardless of the pathology, hypogonadism can 
induce changes similar to the effects of aging but at an accelerated rate (Bylow et al. 2007, Hanson 
et al., 2011 such as significant reductions in muscle mass, increases in fat mass (van Londen et al., 
2008), and reduced bone mass (Basaria et al., 2002), and physical inactivity (Galvao et al., 2009). 
Suppression of endogenous testosterone levels is also associated with a decrease in 
fractional muscle protein synthesis in younger men (Mauras et al., 1998) and older prostate cancer 
patients (Hanson et al., 2017). Resistance training may be a beneficial strategy to mitigate these 
losses, but studies examining the effects of resistance training to recover muscle atrophy and 
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function in men with hypogonadism show mixed results; with some studies showing attenuated 
regrowth (Kvorning et al., 2006; Nilsen et al., 2014, Winters-Stone et al. 2014), and other studies 
showing increases in muscle strength, muscle function, and lean mass (Hanson et al. 2013, Galvao 
et al. 2010). These mixed results in human research may due to a number of confounding factors 
influencing the responses, such as diet and physical activity levels. To better control for these 
factors and to investigate this relationship further, an animal model is a feasible alternative 
approach.  
Animal models are a justifiable and potential alternative as they have demonstrated 
increased fat mass and decreased muscle mass similar results and behaviors to castration as 
humans do to hypogonadism. Eleven weeks of castration in aged rats showed increased fat mass, 
reduced muscle mass, strength, and bone mass compared to age- and weight-matched controls  
(Gentile et al., 2010). Young castrated rats also exhibit an attenuated weight gain, decreased 
muscle mass (Jiao et al., 2009), decreased food intake, and increased bone resorption (Borst & 
Conover 2006; Borst et al., 2007) compared to sham controls. Castration has also been shown to 
increase expression of ubiquitin ligases, markers of skeletal muscle proteolysis (Pires-Oliveira et 
al., 2010). Moreover, Ibebunjo et al. (2011) showed that castration results in almost complete 
cessation in voluntary wheel running that was restored to normal levels following testosterone 
replacement therapy.  
Hindlimb immobilization is a model widely used to induce muscle atrophy that has been 
shown to significantly reduce muscle mass, muscle fiber size, muscle function, and body weight 
compared to control groups (Brown et al., 2001; Murphy et al., 2011; Childs et al., 2003; Morris 
et al., 2004?). Aged rats typically display less atrophy than younger rats, suggesting that older 
animals may already be experiencing significant reductions in muscle mass prior to the 
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immobilization period (Hepple et al., 2004; Blough et al., 2000). Following 10 days of 
immobilization and 15 days of reloading, young rats appear experienced more atrophy from 
immobilization and exhibited a trend towards increasing soleus mass while older rats lacked the 
ability to completely regrow the atrophied soleus (Childs et al., 2003; Morris et al., 2004). This 
diminished capacity for skeletal muscle regrowth in aged rats may be as a result of decreased 
growth factors, such as testosterone, as a result of aging. Heterochronic parabiosis (surgical pairing 
of young and old animals) restored physiologically normal levels of testosterone and showed 
improvements in muscle weight, and muscle fiber cross-sectional area compared to controls, 
indicating testosterone may have a critical role in mediating the improvements (Sinha et al., 2014).  
Castration results in loss of peak tetanic tension regardless of muscle fiber type or function, 
however, it does not exacerbate hindlimb unloading-related atrophy or peak tetanic tension (Brown 
et al. 2001). While aged rat skeletal muscle typically shows less atrophy as well as diminished 
capacity for skeletal muscle regrowth than young rats, some of which may be due to decreased 
testosterone (Sinha et al., 2014) due to aging, data are lacking that directly assess the role of 
testosterone on load-mediated hypertrophy. 
Muscle mass is regulated by the balance between protein synthesis and degradation 
(Phillips and Van Loon, 2011), with hypogonadism (Mauras et al. 1998; Hanson et al. 2017) and 
immobilization (Cholewa et al. 2017) favoring an environment that promotes muscle loss. High 
protein diets are a common approach used to increase muscle protein synthesis and may be a 
beneficial strategy to help attenuate losses resulting from hypogonadism, immobilization, and 
decreased physical activity. For example, BCAA supplementation attenuates the increase in 
markers of skeletal muscle proteolysis (Jang et al., 2015; Maki et al. 2012) and to partly preserve 
specific transduction proteins that act as regulators of protein synthesis and cell growth in hindlimb 
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immobilized rats (Bajotto et al. 2011). Specifically, leucine supplementation has been shown to 
attenuate muscle mass loss in hindlimb immobilized young rats (Baptista et al., 2010) and to 
suppress reductions in muscle mass in the presence of an otherwise protein-free diet (Sugawara et 
al., 2009).  To our knowledge there are currently no studies in rats that examine the ability of a 
high protein diet to overcome the detrimental effects resulting from castration, however leucine-
rich diets have been shown to help increase muscle protein synthesis (Ventrucci et al., 2004), 
modulate proteasome subunits (Salomao et al., 2010), and attenuate decreases in lean body mass 
(Gomes-Marcondes et al., 2003) in tumor-bearing cachectic rats. The peripheral wasting of muscle 
mass associated with cachexia may be a result of increased protein degradation or decreased 
protein synthesis. The ability of high protein diets to  mitigate losses in cachectic rats indicates 
there may be the ability to mitigate declines resulting from hypogonadism as well.  
Therefore, the aims of this study were two-fold: 1) to examine the effects of testosterone 
status on muscle mass, force, and cross-sectional area during reloading following 10 days of 
immobilization and 2) to determine if a high protein diet attenuates immobilization- and castration-
induced atrophy and enhances load-mediated hypertrophy. We hypothesized combined castration 
and immobilization will not act synergistically to induce greater atrophy than just immobilization 
alone and that suppression of endogenous testosterone will not attenuate adaptions to the reloading 
protocol.  Further, a high protein diet will attenuate atrophy during the immobilization period and 
facilitate better adaptations to reloading compared to castrated mice with a traditional diet. The 
recovery of muscle mass, body weight, muscle force, and cross-sectional area will be similar 
between castrated and sham surgery rats. 
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Research Questions 
 
RQ1: Will combined castration and immobilization act synergistically to induce greater 
muscle atrophy and loss of function than immobilization alone?  
RQ2: Is the muscloskeletal function with reloading following immobilization influenced 
by testsosteone levels? 
RQ3: Does a high protein diet attenuate castrationan- and immobilization-induced atrophy 
and provide a greater anabolic stimulus for recovery during reloading?  
Research Hypothesis 
 
H1: Combined castration and immobilization will act synergistically to induce greater 
atrophy than just immobilization alone. 
H2: Suppression of endogenous testosterone via orchidectomy will not attenuate adaptions 
to the reloading protocol.  
H3: A high protein diet will attenuate atrophy during the immobilization period and 
facilitate better adaptations to reloading compared to castrated mice with a traditional diet.  
Limitations 
 
One limitation to this study is it is a retrospective analysis of previously collected data. 
Retrospective studies are vulnerable as the investigators have no control over exposure or outcome 
measures and must rely on accurate record keeping. Another limitation is the lack of a true control 
group. The non-immobilzed contralateral limb served as the control for each animal, however as 
these rats are young they may still be growing as a part of normal development which potentially 
may have skewed the results (Murphy et al. 2011). However, pilot study data obtained specifically 
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from Sprague-Dawley rats (Krawiec et al. 2005) indicates that unilateral immobilization had no 
effect on the contralateral noncasted leg and served as the justification for this approach in the 
current study.    
Significance of Study 
 
 It is well established that functional overload (i.e. strength training) elicits neural and 
morphological adaptations that may lead to increased muscle strength and muscle hypertrophy but 
relatively few studies have examined the hypertrophic response in the absence of testosterone. 
Moreover, many of these studies produce conflicting results. Protein and amino acid 
supplementation has been widely used as a nutritional countermeasure to increase muscle protein 
synthesis, as well as attenuate muscle protein degradation, but to our knowledge there are currently 
no studies in that examine the ability of a high protein diet to overcome the detriments resulting 
from hypogonadism and reduced activity/immobilization. Functional overload and combined 
protein supplementation may provide additional treatment options for those suffering from 
hypogonadism, as well as provide a potential therapy for prostate cancer patients undergoing 
androgen-deprivation therapy. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
In this review, the effects of hypogonadism on skeletal muscle, body composition, and 
contractile properties of muscle of both humans and rats will be examined. It will also examine 
the use of hindlimb immobilization in rats as a model of muscle atrophy, and subsequent reloading 
as a model of functional overload (e.g.strength training). Finally, the potential anabolic effects of 
increased protein intake on recovery from muscle atrophy and castration will be examined. It has 
been established that functional overload facilitates neural and morphological adaptations that can 
lead to increased muscle force and hypertrophy in the eugonodal state; however studies present 
conflicting results as to the effectiveness of strength training in the hypogonadal state and none to 
our knowledge have included protein supplementation in patients at high risk for declines in 
musculoskeletal function. 
Hypogonadism via Chemical Castration 
 
It is estimated that hypogonadism affects between 2.1 - 12.8% of adult males in the general 
population (Zarotsky 2014). Primary hypogonadism is a result of a defect within the Leydig cells 
of the testes in males, while secondary hypogonadism occurs elsewhere, often within the 
hypothalamic-pituitary gonadal (HPG) axis. Androgen deprivation therapy (ADT) is a form of 
prostate cancer treatment that suppresses male sex hormone production in the body, namely 
testosterone, through preventing the pituitary from releasing lutenizing hormone (LH) or through 
8 
 
the use of antiandrogens antagonists that prevent activation of the androgen receptors (Sharifi 
2010).  
While ADT is an effective treatment for prostate cancer, it can have adverse effects on 
cancer patients in both the short-term and long-term. Hypogonadism results in the abrupt loss of 
endogenous testosterone which resembles the symptoms of aging but presents at an accelerated 
rate (Bylow et al. 2007, Hanson et al. 2011). Galvao et al. (2009) assessed the effects of 36 weeks 
of ADT on whole body and regional muscle, fat, and bone mass and physical activity in men with 
PCa. Their results showed that upper limb, lower limb, trunk, and whole-body lean mass decreased 
by [5.6 (0.6)%, 3.7 (0.5)%, 1.4 (0.5)% and 2.4 (0.4)% (p < 0.01) respectively], while fat mass 
increased in those respective areas [20.7 (3.3)%, 18.7 (2.7)%, 12.0 (2.5)% and 13.8 (2.3)% (p < 
0.001)]. Hip, spine, whole-body, upper limb bone mineral density, and physical activity levels 
decreased as well but not lower limb density as a result of ADT. Van Londen et al. (2008) 
examined the long-term effects of ADT on body composition over a 2 year period. They showed 
that men undergoing acute ADT treatment (mean 3 months) had significant gains in body fat mass 
(1499.56±322.28 g after 12 months, 2167.15±676.45 g after 24 months) as well as losses in lean 
body mass (929.74±296.36 g after 12 months, 1785.81±501.31 g after 24 months) over the 2 year 
period. Men undergoing chronic ADT (mean 31 months) had smaller but still significant changes 
over the 2 year period. These results show that men undergoing ADT experience significant gains 
in body fat mass and losses in lean body mass and suggests that these changes are most pronounced 
at the initiation of ADT. Finally, Basaria et al. (2002) conducted a cross-sectional study to 
determine the effects of ADT on lean body mass, muscle strength, and bone mineral density. They 
showed that men on ADT had significantly lower total-body and lumbar spine bone mineral 
density compared to those not undergoing ADT (p = 0.02). As well, the ADT group had higher fat 
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mass (p = 0.0001) and significantly reduced upper body strength (p = 0.001) compared to the other 
groups. Suppression of endogenous testosterone levels is also associated with a decrease in 
fractional muscle protein synthesis in younger men (Mauras et al. 1998) and older prostate cancer 
patients (Hanson et al. 2017). 
Hypogonadism via Surgical Castration 
 
Animal models have demonstrated similar results to hypogonadism as humans. The most 
common method to induce hypogonadism in animal models is through orchidectomy, a procedure 
in which both testes are surgically removed, to remove endogenous testosterone production. 
Gentile et al. (2010) showed that 21 week old Sprague Dawley castrated rats develop increased fat 
mass (+15g), reduced muscle mass (-50g) and strength, as well as lower bone mass (-1.0g)  as a 
result of castration when compared to age and weight-matched sham rats. 12 month old Wistar 
rats that were 15 weeks post-castration also had lower bone mineral content (-7.9%), bone mineral 
density (-5.7%) and fat-free-mass (-10.8%) compared to rats who underwent sham surgery 
(Vanderschueren et al. 2000). Borst et al. (2006) found that orchiectomized Fischer 344 male rats 
display many of the catabolic effects exhibited in humans with hypogonadism such as significant 
decreases in food intake, body weight, and muscle mass accompanied with increased adiposity and 
bone resorption when compared with Brown-Norway and Wistar rat strains. The orchidectomized 
F344 strain is thus found to be the best rat model for studying the androgenic pathway and the 
reversal of the effects of hypogonadism.  
Hypogonadism not only affects body composition and skeletal muscle mass in animal 
models, it also affects skeletal muscle function as well. Harjola et al. (2000) examined whether 
testosterone administration (40mm silastic implant) or hypogonadism affects the recovery of 
muscle mass and myosin heavy chain (MHC) profile after 1 week of immobilization. Rats in the 
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recovery groups were allowed free cage activity for 2 weeks after immobilization. In all groups 
but the testosterone group the body masses after immobilization were lower than in the control 
group; however, gastrocnemius mass was significantly smaller in all groups after immobilization 
when compared to controls. Further, relative gastrocnemius mass was regained during the 2 week 
recovery period independent of testosterone status. These results suggest that the lack of 
testosterone does not significantly affect the recovery of muscle mass from immobilization using 
a reloading protocol. Brown et al. (2001) examined 6 month old Sprague-Dawley rats that 
underwent either sham or castration surgery, 2 weeks of recovery and then 2 weeks of hindlimb 
unloading to determine the effects of testosterone loss on skeletal muscle contractile properties 
and physical inactivity. They showed that body weight and muscle mass were similar in the 
castrated and sham groups, as well the ratio of peak tetanic tension to muscle mass was 
significantly reduced in the castrated group (p < 0.05). They concluded that orchidectomy results 
in loss of peak tetanic tension regardless of muscle fiber type or function but it does not exacerbate 
HLU-related atrophy and peak tetanic loss. Finally, removal of endogenous testosterone by 
orchidectomy and 7 days of recovery resulted in an almost complete cessation in voluntary wheel 
running but only a small decline in muscle mass in 4 month old C57Bl/6NTac mice. Testosterone 
replacement restored running behavior and muscle mass to normal levels (Ibebunjo et al. 2011).  
Hindlimb Immobilization 
 
Hindlimb immobilization of mouse and rat models using plaster casting techniques have 
widely been used a model to induce muscle atrophy. Hindlimb suspension is another technique 
used for limiting use, activity, or movement by restraining rats from hindlimbs or tails. Although 
both hindlimb suspension and hindlimb immobilization produce significant atrophy in skeletal 
muscles compared to controls, the amount of inactivity in each model differs. Specifically, 
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hindlimb suspension allows for unloaded isotonic contractions while immobilization restricts all 
muscle movement. In addition, both models produce significant atrophy in slow-twitch muscles 
but hindlimb suspension fails to produce significant atrophy in fast-twitch muscle in male rats 
(Bricout et al., 1999; Wineski et al., 2002) while hindlimb immobilization produces atrophy in 
fast-twitch muscle that approaches that of slow-twitch. Therefore in order to fully immobilize the 
hindlimb and investigate the recovery of both slow-twitch and fast-twitch muscles a hindlimb 
immobilization model will be used. Booth et al (1973), examined the effects of a hindlimb 
immobilization using 80 day old Sprague-Dawley rats. After 4 weeks of casting, significant 
reductions in body (-12%), gastrocnemius (-32%), soleus (-26%), and plantaris (-27%) weights of 
rats were shown compared to body weights and estimated muscle weights prior to casting. Murphy 
et al. (2011) showed 12 week old C57Bl/10 mice who underwent 2 weeks of hindlimb 
immobilization had reduced muscle mass (-27% and -28%, respectively) and CSA (-37% and -
34%, respectively) of soleus and extensor digitorum longus muscles when compared to control 
mice. Chakravathy et al. (2000) found significant loss (-31-40%) in gastrocnemius mass after 10 
days of hindlimb immobilization in aged FBN rats. Further, gastrocnemius muscle mass did not 
recover from atrophied values after either the first 3-week or later 9-week recovery periods. Booth 
et al (1977), examined the time course of muscle atrophy during 4 weeks of immobilization using 
female Wistar rats. Muscular atrophy was attenuated when a muscle is stretched (loaded) rather 
than shortened and about 60% of the total atrophy of the gastrocnemius and of the plantaris 
occurred within the first 10 days of immobilization. Finally, Lawler et al (2012), investigated the 
stress response during reloading after 4 weeks of hindlimb immobilization in 4 month old Sprague-
Dawley rats. They showed soleus mass decreased (-55%) with HU and remained depressed (-41%) 
7 days into reloading.  
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It is important to note that just as rat strains have differential responses to castration, aged 
rats respond differently than young rats to hindlimb immobilization. First, aged rats experience 
significant age-related atrophy when compared to younger rats prior to immobilization. Thomson 
et al. (2004) showed significant age-related atrophy in plantaris (-16%) and soleus (-14%) 
compared to control muscles. Hepple et al. (2004) examined young and late middle-aged male 
Fischer 344 x Brown Norway (FBN) hybrid rats to determine the effects of aging on gastrocnemius 
and soleus muscle. Significant age-related atrophy was noted in the gastrocnemius (-10%) and 
triceps surae (-9%) muscles. In addition, the duration of physical activity over a 70 hour period 
was 34% lower in late middle-aged FBN rats than the young FBN rats. A comparison of old 
(Morris et al., 2003) and young rats (Childs et al., 2003) showed old rats experienced less atrophy 
(19.2%) than young rats (38.5%) in response to 10 days of hindlimb immobilization. Finally, 
Zarzhevsky et al. (2000) examined the recovery from hindlimb immobilization in 24 month old 
female Wistar rats. They found 4 weeks of hindlimb immobilization caused reductions in wet 
weights of the gastrocnemius (-41%), plantaris (-47%), quadriceps (-44%) and soleus (-40%) of 
rats and after 4 weeks of reloading the muscles failed to return to the control weights. A comparison 
of a similar hindlimb immobilization and reloading in young (6 months old) rats showed 
immobilization resulted in atrophy [gastrocnemius (-58%), plantaris (-47%), quadriceps (-62%) 
and soleus (-47%)] compared to the aged rats and that reloading caused a substantial recovery in 
the hindlimb muscles with them reaching almost complete recovery to control levels.  These 
studies suggest that aged rats experience significant reductions in muscle mass as a result of aging 
which results in aged rats experiencing less atrophy in response to immobilization compared to 
younger rats.  
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Strength Training to reduce effects of Hypogonadism 
 
  It has been established that strength training facilitates neural and morphological 
adaptations that can lead to increased muscle strength and muscle hypertrophy in the presence of 
endogenous testosterone and the eugonadal state (Kraemer et al. 2003, Tipton et al. 2001). 
However, studies examining the effects of resistance training to recover muscle atrophy and 
function in men with induced hypogonadism show mixed results. Certain groups show in 
hypogonadal men that strength training is associated with the preservation of lean mass but the 
regrowth is attenuated compared to controls. Kvorning et al. (2006), investigated the role of 
testosterone for increasing muscle mass and muscle strength in a group of young men with minor 
strength training experience. The subjects were randomized to treatment with the GnRH agonist 
goserelin or placebo subcutaneously every 4 weeks for 12 weeks. The goserelin group showed no 
changes in isometric knee extension strength after training, whereas the placebo group increased 
isometric knee strength (p = 0.05). Lean mass of the legs increased in the goserelin (0.37 ± 0.13kg) 
and placebo groups (0.57 ± 0.30 kg) and body fat mass increased in the goserelin group (1.4 ± 1.0 
kg) and decreased in the placebo (0.6 ± 1.2 kg) group. Winters-Stone et al. (2014) investigated 
whether 1 year of resistance training could reverse ADT-related declines in bone mineral density 
among prostate cancer patients. They showed no differences in hip or spine bone mineral 
density  with the exception of L4 BMD which was preserved in the resistance training group (-
0.4%) compared with a loss in the control group (-3.1%). Nilsen et al. (2015) examined the effects 
of a 16-week high-load strength training program on prostate cancer patients on ADT. They 
showed no statistically significant effect on total lean body mass but significant effects were found 
on lean body mass in the upper and lower extremities (0.49 kg, p < 0.01 and 0.15 kg, p < 0.05, 
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respectively). This data suggests that endogenous testosterone is of paramount importance to the 
adaptation to strength training.  
Separate studies in men undergoing ADT show similar adaptations to strength training 
when compared healthy controls. Hanson et al (2013) examined the effects of 12 weeks of strength 
training on black men undergoing ADT for prostate cancer. Strength training significantly 
increased total body muscle mass (2.7%), thigh muscle volume (6.4%), power (17%), strength 
(28%), functional performance (20%), and muscle endurance (110%). Improved muscle function 
was associated with higher functional performance as well (R2 = 0.54). Galvao et al. (2006) 
examined the effects of progressive resistance training in men receiving androgen deprivation 
therapy for prostate cancer. Their results showed that muscle strength (chest press, 40.5%; seated 
row, 41.9%; leg press, 96.3%; p < 0.001), muscle endurance (chest press, 114.9%; leg press, 
167.1%; p < 0.001), and quadriceps muscle thickness increased (15.7%, p < 0.05) significantly 
after training. Significant improvements (+7-27%, p < 0.05) ino measures of physical functioning 
and balance were shown as well. Alberga et al. (2011) examined the effects of age and ADT on 
body composition and fitness following a 24 weeks of resistance or aerobic exercise program in 
prostate cancer patients. For men over the age of 65 lean body mass decreased in the aerobic 
exercise and control groups but it was preserved in the resistance exercise group. The same 
response was noted in those undergoing ADT, as lean body mass decreased in aerobic exercise 
and control groups but not in the resistance exercise group. Galvao et al. (2010) examined the 
combined resistance and aerobic exercise program as a countermeasure to AST-related declines. 
They showed increases in total body lean mass (+1.2%), upper body lean mass (+3.2%) and lower 
body lean mass mass (+1.2%) as well as increases in muscle strength as well. This data indicates 
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that strength training may influence muscle hypertrophy and strength even in the absence of 
testosterone and could be an effective treatment for the adverse functional consequences of ADT.  
Animal models present a unique challenge as they cannot undergo the same strength 
training protocols as humans. Therefore researchers use different strategies to achieve functional 
overload in animal models. One such strategy is through surgical ablation of synergistic muscle as 
this technique can be used to induce hypertrophy in intact muscle as the remaining muscle must 
compensate for the loss of the synergist. Blough et al. (2000) performed bilateral ablation of the 
gastrocnemius to functionally overload the fast-twitch plantaris for 8 weeks to examine the effects 
of old age on muscle plasticity. Plantaris wet weight, muscle CSA, average fiber CSA, and peak 
isometric tetanic tension were 44%, 42%, 40%, and 83% lower respectively in old (36 month) 
compared to young (6 month old) Fischer 344 x Brown Norway (FBN) hybrid rats. As well, 
Thomson et al., (2004) used unilateral gastrocnemius ablation in young (8 month) and old (30 
month) Fischer 344 x Brown Norway hybrid rats to examine age-attenuated overload-induced 
hypertrophy. In fast-twitch plantaris muscles, percent hypertrophy with overload was significantly 
attenuated with age (9.7% in old v. 30.0% change in young). Surgical ablation is an invasive 
procedure induces muscle hypertrophy but is a rather extreme and therefore that may not best 
represent normal overload stimulus. 
Another strategy to achieve functional overload is through the use of reloading following 
immobilization. This overload stimulus is achieved by allowing the rat to undergo normal activity 
after atrophy has been induced via immobilization or suspension. Reloading atrophied rat skeletal 
muscle through normal cage activity for has been shown to be sufficient to restore soleus muscle 
weight to control values (Litvinova et al., 2007; Fluck et al., 2003) and increase fiber CSA (Fluck 
et al., 2005) following 14 days of hindlimb suspension. Further, Childs et al. (2003) examined the 
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soleus muscle mass in young rats after 10 days of immobilization and 15 days of reloading through 
normal cage activity and found that younger rats experienced a trend towards increasing soleus 
mass with a 15% increase over the course of the experiment; while Morris et al. (2004) examined 
older rats after a similar immobilization protocol and found that they had attenuated regrowth. This 
model is also effective in achieving muscle hypertrophy but may be better suited for this study as 
it represents a non-invasive and realistic approach to achieving functional overload.  
High Protein Diets   
 
Muscle atrophy is characterized by a shift in the balance between protein synthesis and 
degradation. During limb immobilization, the rate of protein synthesis and degradation is affected 
through unloading of the tissue thereby triggering the ubiquitin proteasome system (UPS), 
specifically the muscle-specific E3 ligases atrogin-1 (Gomes et al. 2001) and MuRF-1 (Bodine et 
al. 2001) to carry out skeletal muscle proteolysis (Taillandier et al. 1996, Goldberg et al. 1996). 
Castration has also been shown to increase expression of atrogin-1 and MuRF-1, markers of 
skeletal muscle proteolysis (Pires-Oliveira et al., 2010).  Studies in rat models show that BCAA 
supplementation attenuates the increase in atrogin-1 and MuRF1 mRNA driven by immobilization. 
Jang et al. (2015) investigated the effects of BCAA administration on muscle atrophy during 
growth in male Wistar rats. Rats underwent hindlimb suspension and half were given oral BCAA 
administration (600mg/kg) daily. After 14 days of hindlimb suspension, BCAA prevented a 
decrease in soleus muscle weight and attenuated atrogin-1 and MuRF1 MRNA expression. Maki 
et al. (2012) examined the effects of BCAA administration (600mg/kg) on hindlimb 
immobilization-induced atrophy in young male Sprague-Dawley rats. Hindlimb suspension 
significantly reduced soleus muscle weight and muscle fiber CSA and increased atrogin-1 and 
MuRF1. They showed that BCAA administration significantly attenuated the decrease in CSA and 
17 
 
attenuated the increases in atrogin-1 and MuRF1 in soleus muscles. As well, Bajotto et al. (2011) 
found that BCAA supplementation partly preserves specific transduction proteins, such as cyclin 
D1, that act as regulators of protein synthesis and cell growth, and reduced the loss myofibrillar 
proteins in the soleus of hindlimb immobilized rats.  
Specifically, leucine supplementation has been shown to attenuate muscle mass loss in 
hindlimb immobilized young rats and suppress reductions in muscle mass in the presence of an 
otherwise protein-free diet. Baptista et al. (2009) assessed the effects of leucine supplementation 
on elements of ubiquitin-proteasome system (UPS) in rat skeletal muscle during immobilization. 
They showed that leucine supplementation attenuates soleus muscle mass loss driven by 
immobilization (p < 0.05). Leucine supplementation also abrogated the transient increase in 
MuRF1 and atrogin-1 gene expression during immobilization (p < 0.05). Sugawara et al. (2009) 
examined the effects of long-term leucine intake in dietary protein malnutrition on muscle protein 
synthesis and degradation. They showed that a reduction in muscle mass was suppressed by leucine 
supplementation in rats fed a protein-free diet for 7 days. Ubiquitin ligase mRNA (atrogin-1 and 
MuRF1) expression were not suppressed with leucine supplementation, but protein light chain 3 
active form (LC3-II), an autophagy marker, expression was significantly decreased. These results 
suggest that BCAA and leucine supplementation attenuates muscle wasting induced by 
immobilization and may reduce markers of skeletal muscle protein degradation. However, no 
studies were found that examine the influence of a high protein diet and measures of muscle force, 
suggesting that there is a lack of data exploring this relationship.  
In summary, the loss of endogenous testosterone, as a result of normal aging or 
pharmacological intervention for prostate cancer therapy, has adverse effects on skeletal muscle 
mass, strength, function, and physical activity levels in both humans and rats. Functional overload, 
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either as strength training in humans or synergistic ablation or immobilization with reloading in 
rodent models, has been used to help restore muscle mass and function following significant 
atrophy. However studies examining the ability of strength training to recover muscle atrophy and 
function in men with induced hypogonadism show mixed results. Combined castration and 
hindlimb immobilization has been used as a model to investigate the effects of hypogonadism and 
skeletal muscle atrophy in rats. As well, BCAA and leucine supplementation have been shown to 
help decrease the amount of protein degradation by attenuating increases in ligases of the 
ubiquitin-proteasome system in rats. However, to our knowledge there are currently no studies that 
examine the ability of a high-protein diet overcome detriments as a result of castration or the ability 
of combined reloading and a high-protein diet to reverse the effects of immobilization-induced 
atrophy. The results of this study will help elucidate the role of testosterone on load-mediated 
hypertrophy, as well as examine the ability of combined reloading and a high protein diet to help 
counteract the detrimental effects of castration and immobilization-induced atrophy in rats. 
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CHAPTER III 
METHODOLOGY 
 
Animals. All experiments and procedures were approved by the Animal Ethics Committee at 
Victoria University and in accordance with the Australian code of practice for the care and use of 
animals in scientific research. 110 postpubertal male Fischer 344 rats (~8 weeks, Animal Resource 
Centre, Canning Vale, WA, Australia) were housed in the Centre for Health Research and 
Education at Sunshine Hospital in pairs in a light- and climate-controlled room (12:12 hours of 
light and dark, 20-22°C). The F344 rat has previously been shown to be an appropriate model for 
the adverse effects of hypogonadism (Borst & Conover, 2006). Animals were allowed to acclimate 
for one week before being randomly allocated into castration + chow (N=32), castration + protein 
(N=23), or sham + chow groups (N=36). Testosterone levels were manipulated by performing a 
bilateral orchiectomy or sham surgery via a scrotal incision under sterile conditions (Jiao et al., 
2009). Additional pain relief was administered via intraperitoneal injection 30 minutes prior to 
surgery (0.5mg/kg, Meloxicam, Therapon, Burwood, VIC, Australia). After surgery, animals 
recovered for one week. 
Experimental Protocols. To induce muscle atrophy, the unilateral immobilisation of the right 
hindlimb was utilised for 10 days. Under 2-4% isoflurane anaesthesia, tape stirrups were attached 
to the top and bottom of the foot and the leg was then wrapped in cast padding and compression 
tape. The leg was immobilised by a thermoplastic splint (3’ Vet-lite casting material, Therapon, 
Burwood, VIC, Australia) attached to the outside of the leg. The splint was secured in place using 
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strapping tape with the foot in a neutral position. The splint was inspected and repaired daily, as 
required. After the immobilisation period, animals were anaesthetised and the splints were 
removed. The atrophied muscles were reloaded for 0, 6, or 14 days under normal cage activity 
before muscles were harvested. To establish a baseline group, 14 animals (7 castrated, 7 sham) 
were also sacrificed prior to immobilisation. 
Diet. At the onset of immobilisation, animals were placed on two different diets. Castration + chow 
and sham + chow continued on the standard rodent growth diet (20% protein, AIN93G, Specialty 
Feeds, Glenn Forrest, WA, Australia) whereas the castrate + protein initiated a high protein diet 
(52% protein, SF00-252, Specialty Feeds, Glenn Forrest, WA, Australia) along with branched 
chain amino acids dissolved in their drinking water (~600mg/kg/day, Pro Performance RapidDrive 
BCAA 5000, General Nutrition Company, Pittsburgh, PA, USA). All groups maintained their 
respective diets for the remainder of the study.  
Ex Vivo Contractions. After 0, 6, or 14 days of reloading, animals were anaesthetised with sodium 
pentobarbital (60mg/kg, Therapon, Burwood, VIC, Australia) via intraperitoneal injection. The 
EDL and SOL muscles from both legs were excised tendon to tendon and placed in custom-made 
organ baths (Zultek Engineering, Bayside, VIC, Australia) with Krebs Ringer solution at 30°C. 
Muscles were attached to a force transducer via hooks and optimal length (L0) was established via 
a series of twitch contractions (pulse duration 0.2 msec). L0 was the muscle length producing the 
maximal twitch contraction. Maximal isometric force (P0) was established using a force frequency 
relationship via a series of supramximal contractions (EDL: train duration 350 msec, 15 volts; 
SOL: train duration 500 msec, 12 volts) of increasing frequencies (10 – 200 Hz) separated by 3 
mins of recovery. After completing the contractile experiments, the EDL and SOL were removed 
from the bath, blotted dried, and weighed on an analytical balance. The muscles were divided into 
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separate portions and either snap frozen in liquid nitrogen or mounted in embedding medium and 
frozen in isopentane for future analyses. The remaining plantaris and gastrocnemius muscles were 
then removed from both legs, weighed, and snap frozen in liquid nitrogen. Rats were enthuanised 
via heart excision and any excess fat or vasculature was removed before the heart was weighed 
and frozen. 
Serum Analysis. Serum samples were collected for each animal and stored at -80°C. Total 
testosterone was determined in duplicate via ELISA following the manufacturer instructions 
(Crystal Chem, Downers Grove, IL, USA). 
Muscle Cross Sectional Area. The SOL muscle was cut transversely in a refrigerated cryostat (-
20°C) and stained using haemotoxylin and eosin to determine individual muscle fibre cross 
sectional area. Images were obtained on an automated scanning mircroscope and images were 
quantified using ImageJ software (version 1.49v; Rasband, 1997-2014).  
Statistical Analysis. Analysis were done for muscle wet weights, soleus CSA, and soleus and EDL 
peak tension at 0 days, 6 days, and 14 days of reloading to determine specific differences between 
groups. Groups were compared using a two-way ANOVA (group, casting) with a Tukey HSD post 
hoc for to probe for specific differences within the main effects. The contralateral control limb 
serves as the internal control, thus all comparisons to the immobilized limb are made with the 
contralateral control. Data were analyzed using SPSS version 24.0 statistical software (SPSS Inc., 
Chicago, IL) and expressed as means ± SD. Statistical significance was determined at p < 0.05. 
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CHAPTER IV 
RESULTS 
 
Body Mass 
 
Figure 1. Body mass for sham + chow, castrate + chow, and castrate + protein groups beginning 
with surgery and continuing out to 14 days of reloading. Data are displayed as means ± SD. 
† Significant difference between sham + chow and castrate + protein groups. 
# Significant difference between sham + chow and castrate + chow groups. 
 
 
Body Weight. There were significant group differences beginning at the pre-casting time 
point (p = 0.001) which persisted throughout the entire reloading period (p < 0.001) with both 
castration conditions exhibiting lower body weight than the sham animals. 
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Muscle Wet Weight  
 
Figure 2. EDL muscle wet weight at baseline (prior to immobilization) and after 0 days, 6 days, 
or 14 days of reloading via normal cage ambulation. 
*  Significant difference from control limb p <0.05. 
** Significant difference from control limb p < 0.001. 
 
EDL. There were no significant group x cast interactions. Muscle wet weight was 10.6% and 
10.4% lower in the immobilized vs. the contralateral limb at 0d and 6d (both p < 0.001; Figure 
2), respectively. By 14 days there was no significant difference between the limbs. There were 
no significant group differences at any time point.  
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Figure 3. Gastrocnemius (GAST) muscle wet weight at baseline (prior to immobilization) and 
after 0 days, 6 days, or 14 days of reloading via normal cage ambulation. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
† Significant difference between sham + chow and castrate + protein groups 
# Significant difference between sham + chow and castrate + chow groups 
 
Gastrocnemius. There were no significant group x cast interactions. Similar to EDL, 
casting reduced wet weight significant at 0 days and 6 days (26.6% and 24.6%, both p < 0.001; 
Figure 3) and was no longer statistically different at 14 days (p = 0.064). There was a trend for 
group differences at 14 days (p = 0.056) where both castration conditions exhibited lower muscle 
than the sham + chow group. No differences between castration + chow and castration + protein 
were found. 
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Figure 4. Plantaris (PLT) muscle wet weight at baseline (prior to immobilization) and after 0 
days, 6 days, or 14 days of reloading via normal cage ambulation. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
 
 
 Plantaris. There were no significant group x cast interactions. Immobilization 
significantly reduced muscle wet weight at all time points (all p < 0.05; Figure 4), with the casted 
limb still being 4% less than control at 14 days. At baseline, castration reduced muscle weight (p 
= 0.038) relative to sham but group differences were not detected at any other time points.  
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 Figure 5. Soleus (SOL) muscle wet weight at baseline (prior to immobilization) and after 0 
days, 6 days, or 14 days of reloading via normal cage ambulation. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
† Significant difference between sham + chow and castrate + protein groups 
 
 
Soleus. There were no significant group x cast interactions. Immobilization significantly 
reduced muscle wet weight at all time points (all p < 0.001; Figure 5), with only modest recovery 
being observed by 14 days. No group differences were present at baseline or 0 days, however sham 
+ chow showed a trend to be greater than castration + protein at 6d (p = 0.067) that was significant 
by 14d (p = 0.014). 
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  Figure 6. EDL peak muscle force at baseline (prior to immobilization) and after 0 days, 6 days, 
or 14 days of reloading via normal cage ambulation. SC = Sham + Chow, CC = Castrate + 
Chow, CP = Castrate + Protein. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
 
 
Peak tension (force) 
EDL. There were no significant group x cast interactions. Ten days of immobilization led 
to decreased maximal force production (20.8%, p = 0.007; Figure 6) that was also observed at 6 
days (p = 0.003) but not 14 days. There was a significantly overall effect of group at 6 days (p = 
0.034) on force production. However, post hoc analysis indicated only a trend for reduced force 
production in castration + protein compared to sham (p = 0.076) and castration + chow (p = 0.061). 
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Figure 7. SOL peak muscle force at baseline (prior to immobilization) and after 0 days, 6 days, 
or 14 days of reloading via normal cage ambulation. SC = Sham + Chow, CC = Castrate + 
Chow, CP = Castrate + Protein. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
† Significant difference between sham + chow and castrate + protein groups. 
# Significant difference between sham + chow and castrate + chow groups. 
 
 
Soleus. The loss of force with immobilization was highly pronounced in soleus muscle, 
with large deficits being reported at all three recovery time points (all p < 0.001; Figure 7). 
Significant group differences were observed at 6 days (p = 0.050) and 14d (p = 0.009). Post hoc 
analysis revealed that sham force tended to be greater than castrate + protein (p = 0.063) at 6 days 
and this difference increased by 14 days with both castration groups demonstrating significantly 
less force than sham (both p < 0.05). There were no other group differences or significant 
interactions. 
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Figure 8. SOL cross-sectional area (CSA) at baseline (prior to immobilization) and after 0 days, 
6 days, or 14 days of reloading via normal cage ambulation. 
*  Significant difference from control limb p <0.05 
** Significant difference from control limb p < 0.001 
 
 
Soleus Cross-Sectional Area 
Immobilization decreased SOL cross-sectional area (30.3%, p < 0.001: Figure 8) at 0d and 
while cross-sectional area remained reduced at 14 days, the deficit was smaller (15.9%, p = 0.006). 
Castration appeared to blunt the regrowth of the muscle fibers, but this difference did not reach 
significance. There was a trend for a weak group x cast interaction (p = 0.083), but this failed to 
reach significance as well.  
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Figure 9. Average food intake for sham + chow, castrate + chow, and castrate + protein groups 
beginning with 0 days of reloading and continuing out to 14 days of reloading. 
† Significant difference between sham + chow and castrate + protein groups 
# Significant difference between sham + chow and castrate + chow groups 
& Significant difference between castrate + chow and castrate + protein groups 
 
Average Food Intake 
 There were significant group differences present at all time points (all p < .001). Post hoc 
analysis showed the castrate + protein group consistently had lower food intake than sham + 
chow (p < .001 for all time points: Figure 9) and castrate + chow (p = .001 at 0d, p < .001 for 6d 
and 14d) for all time points, and sham + chow had greater food intake that castrate + chow (p 
<.001) at 14 days of reloading. Further analysis by adjujsting average food weight intake into 
average caloric intake showed that castrate + protein consumed significantly less calories 
throughout compared to both castrate + chow (p = .002) and sham + chow (p < .001). However, 
when adjusting for protein intake in grams per day the castrate + protein group consumed 
significantly more protein throughout compared to castrate + chow and sham + chow groups 
(both p < .001). 
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Figure 10. Average water intake for sham + chow, castrate + chow, and castrate + protein 
groups beginning with 0 days of reloading and continuing out to 14 days of reloading. 
† Significant difference between sham + chow and castrate + protein groups 
& Significant difference between castrate + chow and castrate + protein groups  
 
Average Water Intake 
 There were significant group differences shown at 0 days (p < .001: Figure 10) at and 6 
days (p = .017) of reloading. Post hoc analysis revealed the castrate + protein group had greater 
water intake than sham + chow (p = .003) and castrate + chow (p < .001) at 0 days of reloading, 
and greater intake than castrate + chow (p = .013) at 6 days of reloading.  
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CHAPTER V 
DISCUSSION 
 
 
  The loss of endogenous testosterone has adverse effects on skeletal muscle mass, strength, 
function, and physical activity levels. Functional overload (i.e. strength training) elicits adaptations 
that may attenuate or reverse these effects but relatively few studies have examined the 
hypertrophic response in the absence of testosterone. The current study showed that 10 days of 
hindlimb immobilization significantly reduced muscle wet weights, force, and CSA and these 
changes occurred independent of testosterone levels. During the 14 day reloading period, both 
castration groups displayed a blunted total body weight growth. Locally, significantly lower 
plantaris and gastrocnemius wet weight with 6 days of reloading, and diminished soleus peak 
tension after 14 days of reloading compared to sham animals. Contrary to some of our work in 
humans, functional overload in a testosterone-deprived state appears to attenuate the regrowth of 
skeletal muscle mass and recovery of peak tension, suggesting that testosterone may play a role in 
load-mediated hypertrophy following immobilization. 
  We hypothesized that castration combined with immobilization would act synergistically 
to induce greater atrophy than just immobilization alone, however this was not shown in the present 
study. Ten days of immobilization decreased soleus muscle weight by 34.8% in the castration + 
chow group, 33.8% in the castrate + protein group, and by 36.5% in the sham + chow group, with 
no differences between groups. These findings aligns with previous work from Childs et al. (2003) 
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which showed that 10 days of immobilization decreased soleus muscle weight by 38.5% in young 
rats. There were no significant group differences shown in EDL, gastrocnemius, plantaris or soleus 
muscle wet weight, soleus muscle CSA, or EDL and soleus peak tension at the conclusion of 
immobilization (0 days of reloading in Figures 1-4), indicating that castration did not act 
synergistically to induce greater atrophy and that immobilization appears to be the greater atrophy-
inducing stimulus. This finding agrees with findings from an earlier study by Brown et al. (2001) 
where they showed that castration did not exacerbate hindlimb unloading-related atrophy on 
skeletal muscle contractile properties and physical inactivity. Immobilization also significantly 
reduced force and CSA. Interestingly, soleus appears to have been more affected as mass and peak 
tension both failed to recover compared to the control leg even with 14 days of reloading.  This 
data conflicts with findings from Fluck et al. (2003) that showed that by 14 days of reloading, 
soleus mass had recovered to control values following 14 days of hindlimb suspension.   
  We hypothesized that muscle mass recovery after immobilization would occur independent 
of testosterone status. Contrary to our hypothesis, castration attenuated muscle mass recovery 
following both 6 and 14 days of reloading and protein supplementation did not augment the 
response. Both castration groups exhibited attenuated gastrocnemius mass recovery with 6 days of 
reloading (-12% lower than sham), and soleus mass of the castration + protein group remained was 
significantly lower than sham after 14 days of reloading (-17% lower than sham). Soleus muscle 
recovery at 6 days of reloading is similar to previous work (Childs et al., 2003), with 42% recovery 
in the current study vs. 37% recovery. We also hypothesized that musculoskeletal function would 
recover independent of testosterone status, however after 14 days of reloading soleus peak tension 
was still significantly lower in both castration groups compared to sham indicating that 
34 
 
testosterone may play a role in musculoskeletal function and mass recovery following 
immobilization.  
The attenuated muscle mass recovery is in agreeance with Kvorning et al. (2006) that found 
attenuated increases in lean mass following strength training in hypogonadal men. However, it 
should be noted the studies that show significant increases in lean mass with strength training, such 
as Hanson et al. (2013) and Nilsen et al. (2014), utilized relatively high intensity training protocols; 
with Hanson using a high-intensity protocol combined with heavy resistance at high volume which 
elicited near-maximal effort on all repetitions, and Nilsen using a daily undulating periodization 
model, with a linear progression in training volume through the intervention period. Therefore, the 
significant increases in lean mass in the absence of testosterone may be a result of higher intensity 
training protocols while those that show attenuated increases use lower intensity protocols. This 
may explain the attenuated increases in the present study as well, as the immobilization and 
subsequent reloading model is intended to act as an overload stimulus to induce muscle growth 
following atrophy. However, this model may not place a large enough load on the muscle to be 
considered high intensity and to induce significant atrophy as seen in Hanson et al. (2013) and 
Nilsen et al. (2014).  
The lack of group differences after 14 days of reloading, in all muscles except the soleus, 
represent conflicting findings between muscle mass, CSA, and function within the present study. 
While it seems that muscle mass had recovered with 14 days of reloading, although at an attenuated 
rate, soleus cross-sectional area and peak tension failed to recover compared to the control leg in 
all groups even with 14 days of reloading.  This is unexpected as muscle mass and cross-sectional 
area have been shown to be correlated (Kim et al., 2015; Hansen et al., 2007), therefore increases 
in one should typically exhibit similar increases in the other. We considered that the 
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immobilization protocol may have damaged the muscle tissue as immobilization been shown to 
increase oxidative stress which can cause muscle damage (Moylan et al., 2007; Powers et al., 
2011), and as a result increased blood flow to damaged muscle. This means that at the time of 
muscle harvesting, edema could have accumulated within the tissue and increased muscle wet 
weight. However, if edema was accumulating within the tissue as a result of muscle damage 
centrally located nuclei would be seen indicating the presence of  regenerating fibers, but none 
were found. Another possibility is that mass may be increasing as a result of these rats being young 
and therefore still developing into mature rats. An increase in muscle fiber length as a result of 
normal growth could increase muscle mass, but would not serve to increase muscle cross-sectional 
area or peak tension 
We hypothesized a high protein diet would attenuate atrophy during the immobilization 
period and facilitate better adaptations to reloading compared to castrated rats with a traditional 
diet, however this was not shown in the present study. In fact,  castrate + protein group had 
significantly lower soleus peak tension and soleus mass after 14 days of recovery compared to the 
sham + chow groups, and the castrate + protein group exhibited a trend towards worse adaptations 
to reloading than the castrate + chow group in some instances. The standard chow diet (AIN93G) 
provides 17.5% of the total calories protein whereas the high protein diet (SF00-252) provides 
45.83% of the total calories from protein. Castrate + protein consumed significantly more protein 
per day compared to the other groups by approximately 40-50%. However, the castrate + protein 
group consistently consumed significant less calories per day compared to both the castrate + chow 
(21-34%), and sham + chow (26-38%) groups. A lower daily caloric intake could stunt body 
weight and muscle regrowth as there is potentially a lack of energy available from the diet to 
promote growth. As well, a diet high in protein has been shown to increase satiety and suppress 
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hunger in humans (Martens et al., 201l; Marmonier et al., 2000) and rats (Maurer et al., 2009). 
This means that despite this group having a larger daily intake of protein compared to the other 
groups, they were likely eating less as a result of increased satiety from high protein diet. 
Moreover, increased protein intake increases thirst and increased water intake as result of this 
increased thirst may result in lowered food intake. Additionally, the high protein diet is composed 
of primarily casein, which has been shown to be less effective in promoting protein (or muscle) 
accretion when compared to whey (Pennings et al., 2011).  
There are limitations to this study, one being that is it is a retrospective analysis of 
previously collected data. Retrospective studies are vulnerable as the investigators have no control 
over exposure or outcome measures.. Another limitation is the lack of a true control group. The 
use of a non-immobilized contralateral limb served as the control for each animal in the present 
study, however this is somewhat controversial. In young mice who are still be growing, it was 
argued previously that unilateral immobilization may skew the results (Murphy et al. 2011). Other 
data from Krawiec et al. (2005) in rats indicates that unilateral immobilization had no effect on the 
contralateral non-casted leg. Lastly, immobilization induce muscle atrophy via inactivity that is 
reversed during by overloading the atrophied muscle via normal cage ambulation. As such, this 
stimulus may promote a muscular endurance phenotype rather than muscular strength and may not 
be an appropriate analog to study the effects of strength training. However, there are inherent 
limitations in studying the adaptions to functional overload in animals, given they cannot perform 
traditional strength training protocols that would be analogous to human exercise interventions.  
In summary, our data suggests that testosterone influences the hypertrophic response as 
castrated rats exhibited attenuated muscle regrowth following immobilization compared to sham 
rats. As well, the deviation between the muscle weight and muscle function measures may be as a 
37 
 
result of increased muscle mass resulting from increased fiber length as opposed to increased 
muscle thickness. Further, the high protein diet did not attenuate immobilization-induced atrophy, 
nor did it facilitate greater adaptations to reloading in castrated rats compared to chow diet. This 
appears to be the result of decreased daily food intake (and lower total calories) from increased 
satiety and water intake as a result of the high protein diet. Future studies in rats using a high 
protein diet should aim to control for daily food intake and may explore possibility of a high protein 
diet composed of whey protein as opposed to casein.  
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